(Source: codon AG) 27.02.2013 13:03 co. AG: positive business performance in 2012 Teltow, 27.07.2013 - co. AG, one of the leading companies in the production of autologous cartilage cell transplants for the treatment of articular and vertebral damage, can look back on a positive financial year 2012. The strategy of securing the Germany market - also as a reference for the planned international activities - is succeeding. According to preliminary figures, revenue here rose by about 21% (unaudited). Including the sales performance in foreign markets, total revenue growth of around 16% to €2.7m was achieved in 2012 (unaudited). Thanks to the acquisition of two new investors, co. AG received...
0 Responses to co.don AG: positive business performance in 2012more... (codon AG)